Pharma Design Systems & Multi-Brand Architecture

A major pharma organization's digital ecosystem had grown organically across more than 15 therapeutic brands. Each team had its own design language, its own information architecture, its own approach to regulatory review. The result wasn't a system. It was 15 systems pretending to be one.

The cost was real. Operational inefficiency. Inconsistent patient and HCP experiences. Compliance risk that varied brand by brand. A speed-to-market problem in therapeutic spaces where launch timing matters in millions of dollars. Resource waste across 60+ team members running concurrent projects without shared infrastructure.

The leadership team needed digital governance that could support a multi-billion dollar therapeutic portfolio without slowing the brand teams down.

I led the architecture and governance of three enterprise design systems, each serving a different audience and use case across the portfolio.

The work happened in three layers. The first was strategic — direct partnership with CTOs and senior business strategists on multi-million dollar digital initiative planning, including ROI documentation that could be reported to the board.

The second was architectural — defining the modular component logic, taxonomy, and content frameworks that would govern brand work across the portfolio. Each brand operates inside its own sandbox, working out particular content needs and creative expression within the governance framework. The system is intentionally restrained. Working with copywriters, medical strategists, and regulatory partners, I helped brand teams build information architecture that served both the system and the scientific story.

The third was operational — a governance training program shared with copy, design, and media partners. The training teaches the correct way to leverage the system, the tolerance to which it can be modified, and best practices for initial setup. The goal isn't compliance enforcement. It's knowledge sharing.

A specific innovation worth naming: I led the development of distribution channels for the Patient Design System, including a QR-based mobile wallet card for iOS and Android that gives patients fast access to co-pay information and medication support. It was an industry-first in pharma — only possible when the design system is built to support new patterns instead of resisting them.